1. Choi IH, Lee HK. Treatment of non-tuberculous infection of the spine. J Korean Orthop Assoc. 1984; 19:472–82.
2. Goodman BS, Posecion LW, Mallempati S, et al. Complications and pitfalls of lumbar interlaminar and transforaminal epidural injections. Curr Rev Musculoskelet Med. 2008; 1:212–22.
Article
3. Cherubin CE, Corrado ML, Nair SR, et al. Treatment of Gram-negative bacillary meningitis: role of the new cephalosporin antibiotics. Rev Infect Dis. 1982; 4:453–64.
Article
4. Landesman SH, Corrado ML, Shah PM, et al. Past and current roles for cephalosporin antibiotics in treatment of meningitis. AmY Med. 1981; 71:693–703.
Article
5. Olson DA, Hoeprich PD, Nolan SM, et al. Successful treatment of Gram-negative bacillary meningitis with Moxa-lactam. Ann Intern Med. 1981; 95:302–5.
Article
6. Stratton CW. Serratia marcescens. Infect Control. 1983; 4:469–71.
7. Chang CJ, Ye JJ, Yang CC, et al. Influence of Third-generation Cephalosporin Resistance on Adult In-hospital Mortality From Post-neurosurgical Bacterial Meningitis. J Microbiol Immunol Infect. 2010; 43:301–9.
Article
8. Wu YM, Hsu PC, Yang CC, et al. Serratia marcescens meningitis: Epidemiology, prognostic factors and treatment outcomes. J Microbiol Immunol Infect. 2013; 46:259–65.
Article
9. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med. 1993; 328:21–8.
10. Sigurardottir B, Bjornsson OM, Jonsdottir KE, et al. Acute bacterial meningitis in adults: a 20-year overview. Arch Intern Med. 1997; 157:425–30.